The US Food and Drug Administration has accepted the implementation of the first telemedicine robot intended for remote doctor-to-patient diagnosis, Bedford,Mass.-based iRobot (IRBT) announced Thursday.The RP-Vita Remote PresenceRobot, built by iRobot and privately held InTouch Health, uses advanced telecommunications and autonomous navigation technology.
The FDA has approved the RP-Vita consultation for telemedicine in the field of cardiovascular, neurological, prenatal, psychological and critical care assessments and examinations. The robot can be utilized in emergency rooms for surgeries and patient supervision. Continue reading